174 related articles for article (PubMed ID: 35938343)
1. Longitudinal change in serum inflammatory markers in women with tubo-ovarian abscess after successful surgical treatment: a retrospective study.
Saçıntı KG; Şükür YE; Oruç G; Özmen B; Sönmezer M; Berker B; Atabekoğlu CS; Aytaç R
J Obstet Gynaecol; 2022 Oct; 42(7):3158-3163. PubMed ID: 35938343
[TBL] [Abstract][Full Text] [Related]
2. The prediction of surgical intervention in patients with tubo-ovarian abscess.
Hwang JH; Kim BW; Kim SR; Kim JH
J Obstet Gynaecol; 2022 Jan; 42(1):97-102. PubMed ID: 33629630
[TBL] [Abstract][Full Text] [Related]
3. Can the Need for Invasive Intervention in Tubo-ovarian Abscess Be Predicted? The Implication of C-reactive Protein Measurements.
Ribak R; Schonman R; Sharvit M; Schreiber H; Raviv O; Klein Z
J Minim Invasive Gynecol; 2020 Feb; 27(2):541-547. PubMed ID: 31479751
[TBL] [Abstract][Full Text] [Related]
4. Impact of early surgical management on tubo-ovarian abscesses.
Zhu S; Ballard E; Khalil A; Baartz D; Amoako A; Tanaka K
J Obstet Gynaecol; 2021 Oct; 41(7):1097-1101. PubMed ID: 33249968
[TBL] [Abstract][Full Text] [Related]
5. Serum procalcitonin levels together with clinical features and inflammatory markers in women with tubo-ovarian abscess for discriminating requirements for surgery for full recovery.
Karaca K; Ozkaya E; Kurek Eken M; Uygun I; Kopuk SY; Alpay M
J Obstet Gynaecol; 2018 Aug; 38(6):818-821. PubMed ID: 29523046
[TBL] [Abstract][Full Text] [Related]
6. Complicated Clinical Course and Poor Reproductive Outcomes of Women with Tubo-Ovarian Abscess after Fertility Treatments.
Fouks Y; Cohen Y; Tulandi T; Meiri A; Levin I; Almog B; Cohen A
J Minim Invasive Gynecol; 2019 Jan; 26(1):162-168. PubMed ID: 29890350
[TBL] [Abstract][Full Text] [Related]
7. Endometriosis is a risk factor for recurrent pelvic inflammatory disease after tubo-ovarian abscess surgery.
Zografou Themeli M; Nirgianakis K; Neumann S; Imboden S; Mueller MD
Arch Gynecol Obstet; 2023 Jan; 307(1):139-148. PubMed ID: 36036826
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of neutrophil to lymphocyte ratio in prediction of medical treatment failure for tubo-ovarian abscess.
Alay I; Kaya C; Karaca I; Eren E; Hosgoren M; Aslanova F; Cengiz H; Ekin M; YaSar L
J Obstet Gynaecol Res; 2019 Jun; 45(6):1183-1189. PubMed ID: 30907061
[TBL] [Abstract][Full Text] [Related]
9. Image-guided drainage management of tubo-ovarian abscess and the role of C-reactive protein measurements in monitoring treatment response: a single-center experience.
Türen Demir E; Energin H; Kilic F
Arch Gynecol Obstet; 2023 Oct; 308(4):1321-1326. PubMed ID: 37389642
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopy versus open surgery for the surgical management of tubo-ovarian abscess (TOA). Is there a beneficial impact of early endoscopic intervention in terms of fertility rates?
Sönmezer M; Saçıntı KG; Varlı B; Şükür YE; Gülümser Ç; Özmen B; Atabekoğlu CS; Berker B; Aytaç R; Sönmezer M
Ginekol Pol; 2023; 94(2):95-100. PubMed ID: 36448349
[TBL] [Abstract][Full Text] [Related]
11. Bilateral or unilateral tubo-ovarian abscess: exploring its clinical significance.
Yagur Y; Weitzner O; Shams R; Man-El G; Kadan Y; Daykan Y; Klein Z; Schonman R
BMC Womens Health; 2023 Dec; 23(1):678. PubMed ID: 38115034
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of patients with tubo-ovarian abscess(es) in association with salpingitis.
Hager WD
Obstet Gynecol; 1983 Jun; 61(6):680-4. PubMed ID: 6843924
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Serum Procalcitonin Levels in Predicting Tubo-Ovarian Abscess in Patients with Acute Pelvic Inflammatory Disease.
Erenel H; Yilmaz N; Oncul M; Acikgoz AS; Karatas S; Ayhan I; Aslan B; Tuten A
Gynecol Obstet Invest; 2017; 82(3):262-266. PubMed ID: 27592364
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with an unfavorable clinical course in hospitalized patients with pelvic inflammatory disease: a retrospective cohort study of 117 patients from a Japanese academic institution.
Matsuda N; Jwa SC; Tamura S; Suzuki H; Takamura M; Namba A; Kajihara T; Okagaki R; Kamei Y; Ishihara O
BMC Womens Health; 2022 Aug; 22(1):348. PubMed ID: 35978309
[TBL] [Abstract][Full Text] [Related]
15. Surgical Intervention in Patients with Tubo-Ovarian Abscess: Clinical Predictors and a Simple Risk Score.
Fouks Y; Cohen A; Shapira U; Solomon N; Almog B; Levin I
J Minim Invasive Gynecol; 2019; 26(3):535-543. PubMed ID: 29966713
[TBL] [Abstract][Full Text] [Related]
16. Comparison of severe pelvic inflammatory disease, pyosalpinx and tubo-ovarian abscess.
Kim HY; Yang JI; Moon C
J Obstet Gynaecol Res; 2015 May; 41(5):742-6. PubMed ID: 25363239
[TBL] [Abstract][Full Text] [Related]
17. The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience.
Demirtas O; Akman L; Demirtas GS; Hursitoglu BS; Yilmaz H
Arch Gynecol Obstet; 2013 Mar; 287(3):519-23. PubMed ID: 23104053
[TBL] [Abstract][Full Text] [Related]
18. Experience of Tubo-Ovarian Abscess: A Retrospective Clinical Analysis of 318 Patients in a Single Tertiary Center in Middle Turkey.
Inal ZO; Inal HA; Gorkem U
Surg Infect (Larchmt); 2018 Jan; 19(1):54-60. PubMed ID: 29148955
[TBL] [Abstract][Full Text] [Related]
19. The value of ultrasonographic tubo-ovarian abscess morphology in predicting whether patients will require surgical treatment.
Kinay T; Unlubilgin E; Cirik DA; Kayikcioglu F; Akgul MA; Dolen I
Int J Gynaecol Obstet; 2016 Oct; 135(1):77-81. PubMed ID: 27381446
[TBL] [Abstract][Full Text] [Related]
20. Can antibiotic treatment failure in tubo-ovarian abscess be predictable?
Akselim B; Karaşin SS; Demirci A; Üstünyurt E
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():253-257. PubMed ID: 33482459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
